Literature DB >> 16970875

Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants.

Piero Pavone1, Enrico Parano, Renata Rizzo, Rosario R Trifiletti.   

Abstract

Streptococcal infection in children is usually benign and self-limited. In a small percentage of children, prominent neurologic and/or psychiatric sequelae can occur. Sydenham chorea is the best defined and best recognized. PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection) is a well-defined syndrome in which tics (motor and/or vocal) and/or obsessive-compulsive disorder consistently exacerbate in temporal correlation to a group A beta-hemolytic streptococcal infection. PANDAS constitutes a subset of children with tics, Tourette syndrome, and obsessive-compulsive disorder. In addition to strictly defined PANDAS, we and others have recognized several PANDAS variants, including adult-onset variant, a dystonic variant, a myoclonic variant, and a "chronic" PANDAS variant. The nosology and classification of these entities are rapidly evolving. The recognition that some pediatric neurobehavioral syndromes have infectious and/or immunologic triggers points to important new avenues of disease treatment. In this review, we summarize this complex and rapidly evolving area of clinical research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16970875     DOI: 10.1177/08830738060210091401

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  25 in total

Review 1.  The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates.

Authors:  Alexander V Dmitriev; Michael S Chaussee
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

Review 2.  Tourette syndrome and obsessive-compulsive disorder.

Authors:  Paul J Lombroso; Lawrence Scahill
Journal:  Brain Dev       Date:  2007-10-15       Impact factor: 1.961

Review 3.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

4.  Streptococcal infection and immune response in children with Tourette's syndrome.

Authors:  Erzhen Li; Yiyan Ruan; Qian Chen; Xiaodai Cui; Lingyun Lv; Ping Zheng; Liwen Wang
Journal:  Childs Nerv Syst       Date:  2015-05-01       Impact factor: 1.475

Review 5.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: an overview.

Authors:  S Esposito; S Bianchini; E Baggi; M Fattizzo; D Rigante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-24       Impact factor: 3.267

Review 6.  Neuropsychiatric Aspects of Infectious Diseases: An Update.

Authors:  Sahil Munjal; Stephen J Ferrando; Zachary Freyberg
Journal:  Crit Care Clin       Date:  2017-07       Impact factor: 3.598

7.  Extrapyramidal examinations in psychiatry.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Innov Clin Neurosci       Date:  2012-07

8.  Association of Streptococcal Throat Infection With Mental Disorders: Testing Key Aspects of the PANDAS Hypothesis in a Nationwide Study.

Authors:  Sonja Orlovska; Claus Høstrup Vestergaard; Bodil Hammer Bech; Merete Nordentoft; Mogens Vestergaard; Michael Eriksen Benros
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

9.  Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome.

Authors:  F Brilot; V Merheb; A Ding; T Murphy; R C Dale
Journal:  Neurology       Date:  2011-03-16       Impact factor: 9.910

10.  New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6.

Authors:  Rafael Garcia-Lopez; Emilio Perea-Milla; Cesar Ruiz Garcia; Francisco Rivas-Ruiz; Julio Romero-Gonzalez; Jose L Moreno; Vicente Faus; Guadalupe del Castillo Aguas; Juan C Ramos Diaz
Journal:  Trials       Date:  2009-03-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.